Search

everythinglearnresearchcommunity

for

Search:↓

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Higher prolactin levels in women may be linked to pilonidal sinus disease.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Cortisol and corticosterone thin mouse skin and regress hair follicles, while testosterone promotes skin and hair development.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

150 kHz electromagnetic radiation may improve polycystic ovary condition in rats.

150 kHz Electromagnetic Radiation seems to reduce the number and size of ovarian cysts in rats with PCOS, with minimal changes in developing follicles.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Cyclosporin A does not change sex hormone levels.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

DNA flow cytometry effectively evaluates how different conditions affect hair growth cell activity.

Metformin is less effective in men with early-onset hair loss.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Abnormal adrenal function is not the cause of alopecia in Pomeranians; it may be due to breed-specific hormones.

Ecklonia cava improves the effectiveness of Diane-35 in managing PCOS symptoms.

Thai males with hair loss have lower hair density in the occipital scalp compared to other Asians.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Young people are losing hair due to stress, poor diet, pollution, and lack of sleep, but it can be treated with supplements and scalp treatments.